36C25624Q0918.pdf

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

598-24-2-225-4083

36C25624Q0918 06-11-2024

Tammie Chaney 601-362-4471 ext 56372 06-21-2024

10:00 CDT

00256 Department of Veterans Affairs G.V. (Sonny) Montgomery VAMC Network Contracting Office 16 715 South Pear Orchard Road Ridgeland MS 39157

X

325412

1300 Employees

N/A

X

00598

Department of Veterans Affairs Central Arkansas Veterans Health Care System 4300 West 7th Street Little Rock AR 72205

10N16

Department of Veterans Affairs G.V. (Sonny) Montgomery VAMC A&MM Service (90C) 715 South Pear Orchard Road Ridgeland MS 39157

FSC e-Invoice Payment http://www.fsc.va.gov/fsc/einvoice.asp Invoice Setup Information 1-877-489-6135 invoice must be submitted electronically

1-877-489-6135

See CONTINUATION Page

This acquisition is for the supply of radiopharmaceuticals to the Central Arkansas Veterans Healthcare System via an IDIQ with a five-year ordering period in accordance with the Statement of Work and Price/Cost Schedule.

See Addendum to Instructions to Offerors for quotation submission instructions.

See CONTINUATION Page

X X

X 1

Tammie Chaney

36C25624Q0918

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 STATEMENT OF WORK

B.3 PRICE/COST SCHEDULE

ITEM INFORMATION

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (NOV 2023)

C.2 52.216-2 ECONOMIC PRICE ADJUSTMENT—STANDARD SUPPLIES (NOV

2021)

C.3 52.216-18 ORDERING (AUG 2020)

C.4 52.216-19 ORDER LIMITATIONS (OCT 1995)

C.5 52.216-22 INDEFINITE QUANTITY (OCT 1995)

C.6 52.217-6 OPTION FOR INCREASED QUANTITY (MAR 1989)

C.7 52.217-7 OPTION FOR INCREASED QUANTITY—SEPARATELY PRICED LINE

ITEM (MAR 1989)

C.8 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR

1984)

C.9 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV

2018)

C.10 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) ..56

C.11 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.12 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (FEB 2024)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (SEP 2023)

E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS

AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.3 52.204-29 FEDERAL ACQUISITION SUPPLY CHAIN SECURITY ACT

ORDERS—REPRESENTATION AND DISCLOSURES (DEC 2023)

E.4 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.5 52.216-1 TYPE OF CONTRACT (APR 1984)

E.6 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.7 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.8 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.9 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

E.10 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (FEB 2024)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C256

Department of Veterans Affairs

G.V. (Sonny) Montgomery VAMC

Network Contracting Office 16

715 South Pear Orchard Road

Ridgeland MS 39157

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[ ] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] Monthly

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

Requests. Invoicing shall be in accordance with the requirements of The Department of Veterans Affairs (VA) Financial Services Center (VAFSC). The latest information shall be used for invoicing and payments and may change during the Period of Performance of this acquisition. Current Invoicing information is located at http://www.fsc.va.gov/einvoice.asp

NOTE: The contractor must submit a signed “Final Invoice Memo” (template located in Section D) along with the final invoice for final payment or within seven (7) calendar days after the period of performance or contract expiration whichever is applicable at that time. The Contractor must send one signed copy to the Contracting Officer or the Contracting Officer’s Representative or the assigned Ordering Officer. Failure to submit a signed “Final Invoice Memo” could result in a negative CPARS entry as a lack of business-like concern for the interest of the customer. Notwithstanding the claim period Stated in FAR 52.233-1, Disputes, and pursuant to FAR 33.206, Initiation of a Claim, the contractor agrees to submit any claim related to this contract within 12 months after accrual.

5. SECURE FAX: Please review VA Handbook 6500 that requires the following statement on all fax cover sheets be included:

This fax is intended only for the use of the person or office to which it is addressed and may contain information that is privileged, confidential, or protected by law. All others are hereby notified that the receipt of this fax does not waive any applicable privilege or exemption for disclosure and that any dissemination, distribution, or copying of this communication is prohibited. If you have received this fax in error, please notify this office immediately at the telephone number listed above.

6. Mandatory written disclosures required by FAR clause 52.203-13 to the Department of Veterans Affairs, Office of Inspector General (OIG) must be made electronically through the VA OIG Hotline at https://www.va.gov/oig/hotline/ and clicking on "FAR clause 52.203-13 Reporting." If you experience difficulty accessing the website, call the Hotline at 1-800-488-8244 for further instructions.

7. The Contracting Officer will issue a post award orientation letter (in lieu of a conference) for contract orientation purposes in accordance with FAR 42.504.

8. ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

B.2 STATEMENT OF WORK

A. GENERAL INFORMATION

1. Title of Project: Radiopharmaceutical Supplies for Nuclear Medicine at Central Arkansas Veterans Healthcare System (CAVHS).

2. Background: Nuclear Medicine requires that all radiopharmaceuticals be delivered within allowable timeframes. There is a very short for most radiopharmaceuticals needed to perform required tests. In addition, this is a highly regulated service and must meet requirements from the Nuclear Regulatory Commission. Samples must be picked up within a specific timeframe, for example, WBC scans must be picked up within one hour of notification and the returned tagged blood within 3 hours of pick-up.

3. General Scope of Work: The contractor shall provide all resources necessary to accomplish the deliverables described in this statement of work (SOW), except as may otherwise be specified. This shall include delivery of routine orders for next day radiopharmaceuticals by 0630 and delivery within one (1) hour for all urgent or emergent requests for radiopharmaceuticals using the proper transporting protocols and meeting the standard classifications to identify radiation limits established by the Department of Transportation and the Nuclear Regulatory Commission.

4. Performance Period: Five (5)-12-month ordering periods. Ordering period one (1) expected to begin on 7/1/2024.

5. The contractor shall complete the work required under this SOW daily Monday thru Friday and off hours, weekends and Federal holidays as required for emergent or urgent cases from date of award, unless otherwise directed by the Contracting Officer.

6. Type of Contract: Firm-Fixed-Price Indefinite Delivery Indefinite Quantity

B. Radiopharmaceuticals and Supplies

1. The contractor shall provide delivery by 0630 a.m. on all routine orders for radiopharmaceuticals and shall provide delivery within 1 hour for all urgent or emergent requests for radiopharmaceuticals.

2. For all products, the contractor shall provide Non-High Enriched Uranium (Non-HEU) options to the maximum extent possible. High Enriched Uranium (HEU) products shall only be delivered when non-HEU products either do not exist or are temporarily unavailable.

3. The contractor shall ensure that all deliveries to Central Arkansas Veterans Healthcare System (CAVHS) are made following the proper transporting protocol and that the standard classification to identify radiation limits established by the Department of Transportation and the Nuclear Regulatory Commission are met.

4. The contractor shall be (or use) a compounding pharmacy that is licensed by the State Board of Pharmacy in which it is located, and which is in good standing (no actions pending or unresolved such as a probationary period).

5. The contractor shall ensure that all transporting personnel have proper identification and documents when delivering supplies to CAVHS.

6. The contractor shall establish a method to hand-off to the appropriate Nuclear Medicine personnel during delivery.

7. The Contractor shall provide the shipping containers for delivery and return pick-up.

Shipping containers shall comply with all federal and state regulations. This shall include, but not limited to Department of Transportation (DOT), Department of Energy (DOE), United States Nuclear Regulatory Commission (NRC), National Highway Performance Program (NHPP), and Interstate Commerce Commission (ICC) regulations and standards.

8. The contractor shall pick up WBC scans within 1 hour of notification and shall return the tagged blood to CAVHS within 3 hours of time of pick-up.

9. All product labeling shall meet federal and state requirements for radiopharmaceuticals and include a label on both the syringe and on the outside of the unit dose shield. The label shall contain the name and amount of the radiopharmaceutical and the date and time of the calibration at a minimum.

10. The contractor shall ensure that all counts of drugs be correct on delivery, with no more than five errors per year.

11. The contractor shall deliver all products at no additional charge during normal business hours.

12. In times of national supply shortages or unique situations, the Contractor may substitute radiopharmaceuticals after coordination with the COR/ VA nuclear medicine staff.

C. SCHEDULE FOR DELIVERABLES

If for any reason, any deliverable cannot be delivered within the scheduled timeframe, the contractor shall explain why in writing to the Contracting Officer and shall include a firm commitment of when the work will be completed. This notice to the Contracting Officer shall cite the reasons for the delay. The Contracting Officer will then review the facts and issue a response in accordance with applicable regulations.

D. DELIVERY LOCATION

Central Arkansas Veterans Healthcare System 4300 west 7th Street Little Rock, AR 72205

E. Federal Holidays The Federal Holidays (actual days observed by the Federal Government) are:

New Year’s Day Martin Luther King’s Birthday Washington’s Birthday Memorial Day Juneteenth National Independence Day Independence Day Labor Day Columbus Day Veterans Day Thanksgiving Day Christmas Day And any day specifically declared by the President of the United States to be a national holiday.

Note: If the federal holiday falls on a Saturday it will be officially observed on the Friday before the holiday. If the holiday falls on a Sunday, it will be officially observed on the Monday following the holiday.

F. CHANGES TO STATEMENT OF WORK

Any changes to this SOW shall be authorized and approved only through written correspondence from the Contracting Officer. Costs incurred by the contractor through the actions of parties other than the Contracting Officer shall be borne by the contractor.

G. GOVERNMENT RESPONSIBILITIES

Government shall ensure that Nuclear Medicine staff are available to accept delivery of radiopharmaceutical supplies at the CAVHS.

H. CONFIDENTIALITY AND NONDISCLOSURE

It is agreed that:

1. The preliminary and final deliverables and all associated Working papers, application source code, and other material deemed relevant by VA which have been generated by the contractor in the performance of this task order are the exclusive property of the U.S. Government and shall be submitted to the Contracting Officer at the conclusion of the task order.

2. No information shall be released by the contractor. Any request for information relating to this task Older presented to the contractor shall be submitted to the Contracting Officer for response.

3. Press releases, marketing material or any other printed or electronic documentation related to this project, shall not be publicized without the written approval of the Contracting Officer.

I. Quality Surveillance Procedures/Acceptance

The Government shall perform yearly performance evaluations to determine if the Contractor meets the performance standards for providing radiopharmaceuticals. The performance period for the quality surveillance will include the five (5) pricing periods.

CRITERIA STANDARD QUALITY SURVEILLANCE

LEVEL

METHOD

Timeliness Meet daily delivery times at appropriate locations;

Timely invoices

100% Annual Periodic Inspection

Reliability

Routine deliveries (within 24 hours) Emergent deliveries (within 2 hours)

100% 100%

Annual Periodic Inspection

Quality

Radiopharmaceuticals meet quality testing standards; Labeled and shipped correctly

100% Annual Periodic Inspection

Technical Capability

Provide and deliver essential nuclear medicine products according to SOW

100%

Annual Periodic

Compliance

Meet licensing requirements and NRC/DOT regulations related to radiopharmaceuticals

100% Annual Periodic

B.3 PRICE/COST SCHEDULE

The guaranteed minimum contract amount, including for all ordering periods, is $100,000.00 and the maximum contract amount shall not exceed $4,500,000.00.

ITEM INFORMATION

ITEM

NUMBE

R

DESCRIPTION OF

SUPPLIES/SERVI

CES

QUANTI

TY

UNI

T UNIT PRICE AMOUNT

3,500.00 EA _______________

Tc-99m Sestamibi UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

175.00 EA _______________

Tc-99m NaTcO4 UD mCi ( Unit_Dose ) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

1,600.00 EA _______________

Tc-99m Non-HEU NaTcO4 MD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

100.00 EA _______________

Tc-99m Sulfur Colloid UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

75.00 EA _______________

Tc-99m Mebrofenin UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

540.00 EA _______________

Tc-99m Medronate UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

2.00 EA _______________

Tc-99m Pentetate UD ( Aerosol ) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Non_Aerosol ) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

15.00 EA _______________

Tc-99m Exametazime/ Ceretec WBCs Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

4.00 EA _______________

Tc-99m Exametazime UD Ordering Period: 1 POP Begin: 07-01-2024

POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

45.00 EA _______________

Tc-99m Macro Aggregated Albumin Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

50.00 EA _______________

Tc-99m Mertiatide UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

5.00 EA _______________

Tc-99mOxidronate UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ga-67 Gallium Citrate UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Iobenguane Sulfate UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

25.00 EA _______________

I-123 USP NaI 200 uCi Cap Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

30.00 EA _______________

I-131 USP NaI DX Cap mCi ( Base ) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

12.00 EA _______________

I-131 USP NaI TX Cap ( Base ) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

1,500.00 EA _______________

I-131 USP NaI TX Cap (each addt'l mCi) ( mCi ) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

3.00 EA _______________

In-111 Pentetate SDV/Vial Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetreotide UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

33.00 EA _______________

In-111 Autologous WBC Suspension Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide Vial (CCK) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tl-201 Thallous Chloride UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

38.00 EA _______________

UltraTag Vial Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pyrophosphate UD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Bld Kit (Heparin&Hetastarch) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m WBC Bld Kit (Heparin & Hetastarch) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Oxyquinoline MD Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 20 mCi Vial Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 10 mCi Vial Ordering Period: 1 POP Begin: 07-01-2024

POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

8.00 EA _______________

Y-90 Waste Containers (Nalgene Container 2L-case of 6) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

20.00 EA _______________

Technetium Tc99m Tilmanocept Lymphoseek Study Dose Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

24.00 EA _______________

I-123 Ioflupane UD (Curium) Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Callout Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Delivery Charge Ordering Period: 1 POP Begin: 07-01-2024 POP End: 06-30-2025

Tc-99m Sestamibi UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m NaTcO4 UD mCi ( Unit_Dose ) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Non-HEU NaTcO4 MD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Contract Period: Option 1 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mebrofenin UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Medronate UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Aerosol ) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Non_Aerosol ) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime/ Ceretec WBCs Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Macro Aggregated Albumin Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mertiatide UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99mOxidronate UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ga-67 Gallium Citrate UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Iobenguane Sulfate UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 USP NaI 200 uCi Cap Ordering Period: 2 POP Begin: 07-01-2025

POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI DX Cap mCi ( Base ) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap ( Base ) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap (each addt'l mCi) ( mCi ) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetate SDV/Vial Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetreotide UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026

In-111 Autologous WBC Suspension Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide Vial (CCK) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tl-201 Thallous Chloride UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

UltraTag Vial Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pyrophosphate UD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Bld Kit (Heparin&Hetastarch) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m WBC Bld Kit (Heparin & Hetastarch) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Oxyquinoline MD Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 20 mCi Vial Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 10 mCi Vial Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Y-90 Waste Containers (Nalgene Container 2L-case of 6) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Technetium Tc99m Tilmanocept Lymphoseek Study Dose Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Ioflupane UD (Curium) Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Callout Ordering Period: 3 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Delivery Charge Ordering Period: 2 POP Begin: 07-01-2025 POP End: 06-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sestamibi UD Ordering Period: 3 POP Begin: 07-01-2026

POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m NaTcO4 UD mCi ( Unit_Dose ) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Non-HEU NaTcO4 MD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mebrofenin UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Medronate UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027

Tc-99m Pentetate UD ( Aerosol ) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Non_Aerosol ) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime/ Ceretec WBCs Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Macro Aggregated Albumin Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mertiatide UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99mOxidronate UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ga-67 Gallium Citrate UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Iobenguane Sulfate UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 USP NaI 200 uCi Cap Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI DX Cap mCi ( Base ) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap ( Base ) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap (each addt'l mCi) ( mCi ) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetate SDV/Vial Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetreotide UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Autologous WBC Suspension Ordering Period: 3 POP Begin: 07-01-2026

POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide Vial (CCK) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tl-201 Thallous Chloride UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

UltraTag Vial Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pyrophosphate UD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Bld Kit (Heparin&Hetastarch) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027

Tc-99m WBC Bld Kit (Heparin & Hetastarch) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Oxyquinoline MD Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 20 mCi Vial Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 10 mCi Vial Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Y-90 Waste Containers (Nalgene Container 2L-case of 6) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Technetium Tc99m Tilmanocept Lymphoseek Study Dose Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Ioflupane UD (Curium) Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Callout Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Delivery Charge Ordering Period: 3 POP Begin: 07-01-2026 POP End: 06-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sestamibi UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m NaTcO4 UD mCi ( Unit_Dose ) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Non-HEU NaTcO4 MD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mebrofenin UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Medronate UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Aerosol ) Ordering Period: 4 POP Begin: 07-01-2027

POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Non_Aerosol ) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime/ Ceretec WBCs Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Macro Aggregated Albumin Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mertiatide UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028

Tc-99mOxidronate UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ga-67 Gallium Citrate UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Iobenguane Sulfate UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 USP NaI 200 uCi Cap Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI DX Cap mCi ( Base ) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap ( Base ) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap (each addt'l mCi) ( mCi ) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetate SDV/Vial Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetreotide UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Autologous WBC Suspension Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide Vial (CCK) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tl-201 Thallous Chloride UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

UltraTag Vial Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pyrophosphate UD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Bld Kit (Heparin&Hetastarch) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m WBC Bld Kit (Heparin & Hetastarch) Ordering Period: 4 POP Begin: 07-01-2027

POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Oxyquinoline MD Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 20 mCi Vial Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 10 mCi Vial Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Y-90 Waste Containers (Nalgene Container 2L-case of 6) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Technetium Tc99m Tilmanocept Lymphoseek Study Dose Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028

I-123 Ioflupane UD (Curium) Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Callout Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Delivery Charge Ordering Period: 4 POP Begin: 07-01-2027 POP End: 06-30-2028 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sestamibi UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m NaTcO4 UD mCi ( Unit_Dose ) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Non-HEU NaTcO4 MD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mebrofenin UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Medronate UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Aerosol ) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pentetate UD ( Non_Aerosol ) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime/ Ceretec WBCs Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Exametazime UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Macro Aggregated Albumin Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Mertiatide UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99mOxidronate UD Ordering Period: 5

POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ga-67 Gallium Citrate UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Iobenguane Sulfate UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 USP NaI 200 uCi Cap Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI DX Cap mCi ( Base ) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 USP NaI TX Cap ( Base ) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029

I-131 USP NaI TX Cap (each addt'l mCi) ( mCi ) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetate SDV/Vial Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Pentetreotide UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Autologous WBC Suspension Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide Vial (CCK) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tl-201 Thallous Chloride UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

UltraTag Vial Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Pyrophosphate UD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Bld Kit (Heparin&Hetastarch) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m WBC Bld Kit (Heparin & Hetastarch) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Oxyquinoline MD Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 20 mCi Vial Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Xe-133 Xenon Gas 10 mCi Vial Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Y-90 Waste Containers (Nalgene Container 2L-case of 6) Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Technetium Tc99m Tilmanocept Lymphoseek Study Dose Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Ioflupane UD (Curium) Ordering Period: 5

POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Callout Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

After Hours Delivery Charge Ordering Period: 5 POP Begin: 07-01-2028 POP End: 06-30-2029 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

GRAND TOTAL _______________

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (NOV 2023)

(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post-acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered;

and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(c) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.

(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the Contracting Officer of the cessation of such occurrence.

(g) Invoice.

(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—

(i) Name and address of the Contractor;

(ii) Invoice date and number;

(iii) Contract number, line item number and, if applicable, the order number;

(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;

(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;

(vi) Terms of any discount for prompt payment offered;

(vii) Name and address of official to whom payment is to be sent;

(viii) Name, title, and phone number of person to notify in event of defective invoice; and

(ix) Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required elsewhere in this contract.

(x) Electronic funds transfer (EFT) banking information.

(A) The Contractor shall include EFT banking information on the invoice only if required elsewhere in this contract.

(B) If EFT banking information is not required to be on the invoice, in order for the invoice to be a proper invoice, the Contractor shall have submitted correct EFT banking information in accordance with the applicable solicitation provision, contract clause (e.g., 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or 52.232-34, Payment by Electronic Funds Transfer—Other Than System for Award Management), or applicable agency procedures.

(C) EFT banking information is not required if the Government waived the requirement to pay by EFT.

(2) Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management and Budget (OMB) prompt payment regulations at 5 CFR part 1315.

(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.

(i) Payment.—

(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.

(2) Prompt payment. The Government will make payment in accordance with the Prompt Payment Act (31 U.S.C. 3903) and prompt payment regulations at 5 CFR part 1315.

(3) Electronic Funds Transfer (EFT). If the Government makes payment by EFT, see 52.212- 5(b) for the appropriate EFT clause.

(4) Discount. In connection with any discount offered for early payment, time shall be computed from the date of the invoice. For the purpose of computing the discount earned, payment shall be considered to have been made on the date which appears on the payment check or the specified payment date if an electronic funds transfer payment is made.

(5) Overpayments. If the Contractor becomes aware of a duplicate contract financing or invoice payment or that the Government has otherwise overpaid on a contract financing or invoice payment, the Contractor shall—

(i) Remit the overpayment amount to the payment office cited in the contract along with a description of the overpayment including the—

(A) Circumstances of the overpayment (e.g., duplicate payment, erroneous payment, liquidation errors, date(s) of overpayment);

(B) Affected contract number and delivery order number, if applicable;

(C) Affected line item or subline item, if applicable; and

(D) Contractor point of contact.

(ii) Provide a copy of the remittance and supporting documentation to the Contracting Officer.

(6) Interest.

(i) All amounts that become payable by the Contractor to the Government under this contract shall bear simple interest from the date due until paid unless paid within 30 days of becoming due. The interest rate shall be the interest rate established by the Secretary of the Treasury as provided in 41 U.S.C. 7109, which is applicable to the period in which the amount becomes due, as provided in (i)(6)(v) of this clause, and then at the rate applicable for each six-month period as fixed by the Secretary until the amount is paid.

(ii) The Government may issue a demand for payment to the Contractor upon finding a debt is due under the contract.

(iii) Final decisions. The Contracting Officer will issue a final decision as required by 33.211 if—

(A) The Contracting Officer and the Contractor are unable to reach agreement on the existence or amount of a debt within 30 days;

(B) The Contractor fails to liquidate a debt previously demanded by the Contracting Officer within the timeline specified in the demand for payment unless the amounts were not repaid because the Contractor has requested an installment payment agreement; or

(C) The Contractor requests a deferment of collection on a debt previously demanded by the Contracting Officer (see 32.607-2).

(iv) If a demand for payment was previously issued for the debt, the demand for payment included in the final decision shall identify the same due date as the original demand for payment.

(v) Amounts shall be due at the earliest of the following dates:

(A) The date fixed under this contract.

(B) The date of the first written demand for payment, including any demand for payment resulting from a default termination.

(vi) The interest charge shall be computed for the actual number of calendar days involved…